Connect your AI

ADMA Biologics ADMA Operating Cash Flow

Operating Cash Flow at other companies

AbCellera Biologics Inc.ABCL

-$33.52M-190%

AnaptysBio, Inc.ANAB

-$25.92M-142%

ZymeworksZYME

-$45.72M-1,242%

Bio-Rad LaboratoriesBIO

$108.1M-16.8%

Apogee Therapeutics, Inc.APGE

-$55.57M-14.6%

Quest DiagnosticsDGX

$278M-11.5%

Other financials

Income statement

Revenue$114.5M-0.3%

Gross profit$80.8M+32.2%

Operating income$58.3M+67.1%

Net income$45.3M+68.5%

EPS (diluted)$0.19+72.7%

Balance sheet

Cash & equivalents$138.2M+92.9%

Total debt$204.4M+2,055%

Total equity$390.3M+4.5%

Total assets$665.2M+30.3%

Cash flow

CapEx$2.5M-45.9%

Free cash flow$55.7M+329%

Valuation

Market cap$2.01B-54.5%

Enterprise value$2.08B-52.5%

P/E12.2×-9.2×

P/S4×-5.7×

Profitability

Gross margin61.3%+8.7pp

Operating margin42.1%+9.0pp

Net margin32.4%-12.6pp

FCF margin21.2%+1.4pp

Returns & leverage

Return on equity43.3%-35.2pp

Debt / equity0.5×+0.5×

Current ratio7×+0.4×

Where this comes from

Reported directly by ADMA Biologics in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities.

The official record: ADMA Biologics’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about ADMA Biologics's operating cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is ADMA Biologics's operating cash flow?: ADMA Biologics (ADMA) reported operating cash flow of $58.25M in Q1 2026.
How has ADMA Biologics's operating cash flow changed year-over-year?: ADMA Biologics's operating cash flow increased by 396.1% year-over-year, from -$19.68M to $58.25M.
What is the long-term trend for ADMA Biologics's operating cash flow?: Over 4 years (2021 to 2025), ADMA Biologics's operating cash flow has grown at a -18.2% compound annual growth rate (CAGR), from -$112.37M to $50.4M.
What does operating cash flow mean?: Total cash generated by or used in core business operations — the single most important cash flow metric for assessing business health.